NAHT Invest is a forward-thinking venture capital firm dedicated to identifying and nurturing the next wave of technological and healthcare innovations. Based in Vancouver, Canada, with a global presence, we focus on breakthrough technologies set to shape the next two decades. Our mission is to fuel the companies leading the charge toward a smarter, healthier future.
Specializes in advanced colloidal gold technology for various diagnostic applications, significantly contributing to COVID-19 testing efforts in the USA.
Leading provider of IgG testing services and shockwave devices, focused on addressing chronic pain management through innovative healthcare solutions.
A leader in personalized medicine, offering target assay solutions and genetic testing services.
This investment has successfully exited.
Specializes in antigen extraction and is committed to producing IgG and IgE testing protein chip membranes and reagents for precise diagnostics.
A creative community that offers unique solutions, including autonomous driving products and accessories, modular handheld devices, and accessories for the vanlife community.
Utilizes IoT, AI, and big data to process healthcare data, focusing on chronic disease and chronic pain management for improved patient outcomes.
Boston: Spaulding Rehabilitation Hospital Boston
Toronto: University of Toronto's Pardee Lab, Hatchery, and DCSIL
Shanghai: Shanghai Jiao Tong University AI Institute
Guangzhou: Guangzhou Institute of Respiratory Health